Suzuken Co., Ltd.
Suzuken Co., Ltd.
Your view on SZUKF
Overview
What the company does, where it operates, and who runs it.
About Suzuken Co., Ltd.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Shigeru Asano
- Headquarters
- 8 Higashi Kataha-machi, Nagoya, JP
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Shigeru Asano
- Headquarters
- 8 Higashi Kataha-machi, Nagoya, JP
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business.
The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies.
The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases.
The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support.
The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions.
The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Suzuken Co., Ltd., and the rating behind it. SZUKF last traded at $30.30, 9.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Suzuken Co., Ltd.. Starting points for Suzuken Co., Ltd.: P/E 9.5, EPS $560.60, beta 0.14 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Suzuken Co., Ltd.. Suzuken Co., Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Suzuken Co., Ltd.. Trailing twelve-month EPS for Suzuken Co., Ltd. stands at $560.60. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Suzuken Co., Ltd.. Suzuken Co., Ltd. has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Suzuken Co., Ltd. valued side by side against its closest peers. Suzuken Co., Ltd. is measured against Medical - Distribution peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Suzuken Co., Ltd., and how their positions are changing. At a $1.72B market value, institutional positions materially move Suzuken Co., Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Suzuken Co., Ltd. executives and directors. Shares of Suzuken Co., Ltd. have traded between $30.30 and $30.30 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Suzuken Co., Ltd.. Suzuken Co., Ltd. is a $1.72B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Suzuken Co., Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Suzuken Co., Ltd.. Coverage tracks Suzuken Co., Ltd. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.